Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -23.46%47.11M | 1,508.45%3.21B | 107.69%61.55M | -72.94%199.47M | -67.04%29.64M | 140.55%737.03M | 9.02%89.92M | 42.73%306.39M | 71.96%82.47M | 46.84%214.67M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -11.90%-16.05M | ---- | 35.44%-14.34M | ---- | -245.62%-22.21M | ---- | -250.82%-6.43M | ---- | 26.51%-1.83M |
| Dividend (income)- adjustment | ---- | ---35.64M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Investment loss (gain) | ---- | ---- | ---- | 139.07%3.41M | ---- | ---8.72M | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | 62.98%-56.23M | ---- | 37.39%-151.89M | ---- | -15.16%-242.57M | ---- | -15.51%-210.64M | ---- | -85.50%-182.36M |
| Impairment and provisions: | ---- | 63.30%-3.46M | ---- | -114.15%-9.42M | ---- | 170.21%66.56M | ---- | 309.25%24.63M | ---- | 63.52%6.02M |
| -Impairment of property, plant and equipment (reversal) | ---- | --6.22M | ---- | ---- | ---- | --16.28M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | 86.58%-2.37M | ---- | -285.94%-17.63M | ---- | -122.40%-4.57M | ---- | 558.87%20.39M | ---- | 6.98%3.1M |
| -Impairment of trade receivables (reversal) | ---- | 37.08%-3.86M | ---- | -253.14%-6.13M | ---- | -158.12%-1.74M | ---- | --2.99M | ---- | ---- |
| -Other impairments and provisions | ---- | -124.08%-3.45M | ---- | -74.67%14.33M | ---- | 4,405.10%56.58M | ---- | -57.05%1.26M | ---- | --2.92M |
| Revaluation surplus: | ---- | 4,000.51%128.76M | ---- | -203.51%-3.3M | ---- | 189.98%3.19M | ---- | 80.86%-3.54M | ---- | -30,968.33%-18.52M |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | -198.06%-3.13M | ---- | 428.76%3.19M | ---- | -193.00%-970K | ---- | --1.04M |
| -Other fair value changes | ---- | 74,097.70%128.76M | ---- | ---174K | ---- | ---- | ---- | 86.84%-2.57M | ---- | -32,706.67%-19.56M |
| Asset sale loss (gain): | ---- | -187,704.27%-3.25B | ---- | 100.40%1.73M | ---- | -474,626.09%-436.75M | ---- | 83.51%-92K | ---- | -111.71%-558K |
| -Loss (gain) from sale of subsidiary company | ---- | -158,119.46%-3.25B | ---- | 100.47%2.06M | ---- | -93,897.63%-437.09M | ---- | 67.00%-465K | ---- | -4,303.13%-1.41M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 59.88%-130K | ---- | -195.01%-324K | ---- | -8.58%341K | ---- | -56.17%373K | ---- | -82.26%851K |
| Depreciation and amortization: | ---- | 76.88%82.36M | ---- | -13.88%46.56M | ---- | -0.70%54.07M | ---- | 1.83%54.45M | ---- | 7.11%53.48M |
| Financial expense | ---- | 458.25%6.43M | ---- | 22.16%1.15M | ---- | 49.21%943K | ---- | 23.92%632K | ---- | 11.11%510K |
| Unrealized exchange loss (gain) | ---- | 89.63%-925K | ---- | -41.46%-8.92M | ---- | -213.01%-6.31M | ---- | 4.32%5.58M | ---- | --5.35M |
| Special items | ---- | -24.05%3.47M | ---- | 196.62%4.56M | ---- | -34.55%1.54M | ---- | -14.11%2.35M | ---- | -88.07%2.74M |
| Operating profit before the change of operating capital | -23.46%47.11M | 1.00%69.71M | 107.69%61.55M | -52.97%69.02M | -67.04%29.64M | -15.33%146.77M | 9.02%89.92M | 118.06%173.34M | 71.96%82.47M | -37.52%79.49M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -67.58%-37.26M | -90.14%5.74M | -150.26%-22.24M | -29.22%58.18M | 2.51%44.24M | 189.77%82.2M | 164.26%43.16M | -17.56%-91.56M | -367.54%-67.17M | -332.29%-77.88M |
| Accounts receivable (increase)decrease | 101.53%1.14M | -191.06%-69.83M | -329.34%-74.56M | 16.07%76.69M | 268.19%32.51M | 160.60%66.07M | 81.26%-19.33M | -125.10%-109.03M | -312.95%-103.16M | -226.27%-48.43M |
| Accounts payable increase (decrease) | -149.71%-10.89M | 119.62%8.2M | 155.86%21.91M | -23.68%-41.82M | -391.95%-39.23M | -179.81%-33.81M | -110.30%-7.97M | -2.14%42.36M | 90.34%77.4M | 154.95%43.29M |
| Financial assets at fair value (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 239.73%5.66M |
| Special items for working capital changes | 32.20%-3.68M | 178.72%10.33M | 39.97%-5.43M | -39.66%-13.12M | 57.73%-9.05M | -128.68%-9.39M | -1,257.05%-21.42M | 346.74%32.75M | 879.37%1.85M | 226.07%7.33M |
| Cash from business operations | 80.93%-3.58M | -83.79%24.14M | -132.30%-18.77M | -40.85%148.95M | -31.11%58.11M | 426.17%251.83M | 1,080.30%84.36M | 406.20%47.86M | -117.40%-8.61M | -91.44%9.46M |
| Other taxs | -114.03%-1.65M | -42.05%-9.63M | 49.54%-770K | 44.69%-6.78M | 69.08%-1.53M | 21.42%-12.25M | -598.08%-4.94M | -740.02%-15.59M | 153.31%991K | 117.79%2.44M |
| Net cash from operations | 73.25%-5.23M | -89.79%14.52M | -134.53%-19.54M | -40.66%142.17M | -28.75%56.59M | 642.42%239.58M | 1,143.07%79.42M | 171.38%32.27M | -115.99%-7.61M | -87.71%11.89M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 292.67%5.89M | 2.16%9.6M | -80.86%1.5M | -14.05%9.4M | 95.66%7.84M | 150.26%10.93M | 104.39%4.01M | 285.61%4.37M | 306.64%1.96M | -54.55%1.13M |
| Dividend received - investment | -53.90%29.97M | 39.02%65.02M | 39.02%65.02M | 35.51%46.77M | 35.51%46.77M | -4.05%34.51M | -4.05%34.51M | 0.37%35.97M | 67.85%35.97M | 59.65%35.84M |
| Loan receivable (increase) decrease | ---- | -67.20%10.23M | -35.68%10.84M | 1,668.03%31.19M | 887.46%16.85M | -46.29%1.76M | -3.94%1.71M | 111.05%3.28M | 106.24%1.78M | -148,690.00%-29.72M |
| Sale of fixed assets | 228.57%529K | 26.02%557K | 631.82%161K | 36.42%442K | -77.55%22K | 141.79%324K | -5.77%98K | -57.73%134K | -42.86%104K | -25.93%317K |
| Purchase of fixed assets | -16.48%-127.16M | -160.33%-156.79M | -646.16%-109.16M | -78.15%-60.23M | -29.37%-14.63M | 36.45%-33.81M | 56.20%-11.31M | 0.39%-53.2M | 10.56%-25.82M | -29.61%-53.41M |
| Sale of subsidiaries | ---- | --2.2B | ---- | ---- | ---- | --300.31M | --210.97M | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | -59.19%3.71M | -57.17%3.71M | 16.03%9.08M | --8.66M | --7.83M | ---- | ---- |
| Cash on investment | ---141.35M | ---- | ---- | -247.04%-136.46M | -172.74%-107.24M | 13.91%-39.32M | 13.91%-39.32M | ---45.67M | ---45.67M | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --22.61M | --22.61M | ---- |
| Net cash from investment operations | -633.40%-232.11M | 2,119.55%2.12B | 32.21%-31.65M | -137.06%-105.18M | -122.31%-46.69M | 1,249.93%283.8M | 2,405.97%209.31M | 46.16%-24.68M | 74.24%-9.08M | -192.53%-45.84M |
| Net cash before financing | -363.65%-237.34M | 5,681.73%2.14B | -617.23%-51.19M | -92.93%36.99M | -96.57%9.9M | 6,795.69%523.38M | 1,829.87%288.73M | 122.36%7.59M | -234.97%-16.69M | -141.86%-33.95M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 407.91%342.37M | 963.14%166.55M | -25.64%67.41M | -75.27%15.67M | 1,067.22%90.65M | 1,572.54%63.34M | -66.61%7.77M | --3.79M | 469.10%23.26M |
| Refund | 95.17%-4.75M | -793.74%-358.26M | -529.69%-98.26M | 59.20%-40.09M | 76.74%-15.6M | ---98.24M | ---67.09M | ---- | ---- | ---23.18M |
| Interest paid - financing | 90.24%-327K | -458.25%-6.43M | -484.47%-3.35M | -22.16%-1.15M | -8.94%-573K | -49.21%-943K | -74.75%-526K | -23.92%-632K | -29.18%-301K | -11.11%-510K |
| Dividends paid - financing | -2.87%-1.22M | -1,432.34%-1.71B | 45.19%-1.19M | 54.80%-111.49M | 54.62%-2.16M | -899.87%-246.69M | -30.38%-4.76M | 51.91%-24.67M | ---3.65M | 65.55%-51.31M |
| Absorb investment income | ---- | --8.61M | --8.61M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | 57.92%-35.27M | 23.58%-33.6M | -45.14%-83.81M | -67.89%-43.96M | -189.48%-57.75M | -31.27%-26.19M | ---19.95M | ---19.95M | ---- |
| Other items of the financing business | ---- | 12.65%-5.57M | -0.13%-4.69M | 30.41%-6.38M | -0.11%-4.68M | -82.56%-9.17M | 0.11%-4.68M | 9.25%-5.02M | -0.06%-4.68M | 14.64%-5.54M |
| Net cash from financing operations | -123.74%-7.77M | -879.79%-1.77B | 160.41%32.74M | 44.93%-180.21M | -27.52%-54.19M | -591.20%-327.22M | -55.16%-42.49M | 24.26%-47.34M | -265.89%-27.39M | 59.77%-62.51M |
| Effect of rate | 55.66%5.97M | 82.57%-737K | 180.35%3.84M | -2,197.83%-4.23M | 20.43%-4.77M | -109.68%-184K | -411.95%-6M | -76.27%1.9M | -155.41%-1.17M | 160.68%8.01M |
| Net Cash | -1,228.30%-245.11M | 360.48%373.05M | 58.34%-18.45M | -173.01%-143.22M | -117.99%-44.29M | 593.48%196.16M | 658.64%246.24M | 58.79%-39.75M | -1,003.05%-44.08M | -29.83%-96.45M |
| Begining period cash | 243.56%525.18M | -49.10%152.87M | -49.10%152.87M | 187.84%300.31M | 187.84%300.31M | -26.62%104.33M | -26.62%104.33M | -38.35%142.18M | -38.35%142.18M | -27.50%230.63M |
| Cash at the end | 106.90%286.04M | 243.56%525.18M | -44.97%138.25M | -49.10%152.87M | -27.08%251.25M | 187.84%300.31M | 255.47%344.57M | -26.62%104.33M | -59.21%96.93M | -38.35%142.18M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.